US Stock Insider Trading | Dentsply Disclosed One Insider Transaction on February 26

On February 26, 2026, Dentsply Sirona (XRAY) disclosed an insider transaction. Director Scavilla Daniel T sold 1,194 shares on February 24, 2026.

[Recent Insider Transactions]

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
February 26, 2026 Director Scavilla Daniel T February 24, 2026 Sell 1,194 13.14 $15,700
December 10, 2025 Director Lucier Gregory T December 8, 2025 Sell 82,200 11.14 $915,700
December 1, 2025 Executive Johnson Robert Anthony November 28, 2025 Sell 9,030 11.34 $102,400
November 25, 2025 Director Varon Leslie F November 24, 2025 Buy 9,337 10.71 $100,000
August 12, 2025 Executive Frohning Andrea L. August 8, 2025 Sell 788 12.96 $10,200
May 15, 2025 Executive Czerney Kevin May 13, 2025 Sell 432 16.60 $7,171.20
April 15, 2025 Executive Frohning Andrea L. April 11, 2025 Buy 321 1.00 $321.62
March 5, 2025 Director Campion Simon D March 3, 2025 Sell 3,778 15.99 $60,400
March 5, 2025 Executive Rosenzweig Richard C March 4, 2025 Sell 1,440 15.59 $22,400
March 5, 2025 Executive Rosenzweig Richard C March 3, 2025 Sell 6,408 15.99 $102,500

[Company Information]

DENTSPLY SIRONA Inc. is a Delaware corporation. It is the world’s largest manufacturer of professional dental products and technologies, with a 137-year history of innovation and service in the dental industry, and a vision to improve oral health and incontinence care worldwide. Dentsply Sirona develops, manufactures, and markets comprehensive solutions, including technologically advanced dental equipment supported by cloud software solutions, as well as dental products and healthcare consumables under a strong global brand portfolio in urology and gastroenterology. Dentsply Sirona’s products provide innovative, high-quality, and effective solutions to advance patient care and deliver better, safer, and faster dental services.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin